Cargando...
Thymidylate synthase predicts poor response to pemetrexed chemotherapy in patients with advanced breast cancer
Pemetrexed is a candidate chemotherapy regimen for anthracycline- and taxane-pretreated advanced breast cancer. However, to the best of our knowledge, no efficient treatment efficacy biomarkers have been identified. In the present study, the potential correlation between thymidylate synthase (TYMS)...
Gardado en:
| Publicado en: | Oncol Lett |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
D.A. Spandidos
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6096094/ https://ncbi.nlm.nih.gov/pubmed/30127925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8973 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|